Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.



In This Section

Home / News & Media / News Template
Press Release Logo  

Lori Gardner, Senior Director
Membership and Public Relations
301.984.9496 ext. 226


ACCC Voices Strong Opposition to CMS Part B Drug Payment Model

ROCKVILLE, Md. – The Centers for Medicare and Medicaid Services (CMS) released its much anticipated Part B Drug Payment Model yesterday, which proposes to change the way Medicare pays for Part B drugs through a national mandatory program.

The Association of Community Cancer Centers (ACCC) is deeply concerned this experiment will have a detrimental impact on patients and their access to high quality, high value cancer care. The agency has put forward a convoluted plan that will place undue burden on both patients and providers, and significantly hamper providers’ ability to provide critical cancer care services in their communities.

On both policy and process, CMS missed the mark with this proposal. The agency sought no stakeholder input and is providing little turnaround time before implementation of such a sweeping, misguided change in Medicare reimbursement.

ACCC calls on the agency to withdraw the proposal and begin significant stakeholder outreach on sustainable, comprehensive payment reform. We will be submitting detailed comments to CMS that reflect our profound disappointment in this narrow and potentially damaging approach to policymaking.

About the Association of Community Cancer Centers

The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of 25,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve — so has ACCC — adapting its resources to meet the changing needs of the entire oncology care team. For more information, visit or call 301.984.9496. Follow us on Facebook, Twitter, and LinkedIn; read our blog, ACCCBuzz; and tune in to our podcast, CANCER BUZZ.